{"organizations": [], "uuid": "1d9206ce025a462b5f3ca7df5fbba2fbae6ce3b1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-precision-therapeutics-q4-loss-per/brief-precision-therapeutics-q4-loss-per-share-0-43-idUSASC09UJY", "country": "US", "domain_rank": 408, "title": "BRIEF-Precision Therapeutics Q4 Loss Per Share $0.43", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T23:52:00.000+03:00", "replies_count": 0, "uuid": "1d9206ce025a462b5f3ca7df5fbba2fbae6ce3b1"}, "author": "", "url": "https://www.reuters.com/article/brief-precision-therapeutics-q4-loss-per/brief-precision-therapeutics-q4-loss-per-share-0-43-idUSASC09UJY", "ord_in_thread": 0, "title": "BRIEF-Precision Therapeutics Q4 Loss Per Share $0.43", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2 (Reuters) - Precision Therapeutics Inc:\n* PRECISION THERAPEUTICS REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.43 * Q4 REVENUE $220,300 VERSUS $139,600 Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-02T23:52:00.000+03:00", "crawled": "2018-04-03T00:12:37.023+03:00", "highlightTitle": ""}